These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31495331)

  • 1. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
    Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
    Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.
    Steinberg GK; Kondziolka D; Wechsler LR; Lunsford LD; Coburn ML; Billigen JB; Kim AS; Johnson JN; Bates D; King B; Case C; McGrogan M; Yankee EW; Schwartz NE
    Stroke; 2016 Jul; 47(7):1817-24. PubMed ID: 27256670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
    Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
    Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke.
    Urfer R; Moebius HJ; Skoloudik D; Santamarina E; Sato W; Mita S; Muir KW;
    Stroke; 2014 Nov; 45(11):3304-10. PubMed ID: 25270629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
    Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
    Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
    JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
    Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
    Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
    Glassberg MK; Minkiewicz J; Toonkel RL; Simonet ES; Rubio GA; DiFede D; Shafazand S; Khan A; Pujol MV; LaRussa VF; Lancaster LH; Rosen GD; Fishman J; Mageto YN; Mendizabal A; Hare JM
    Chest; 2017 May; 151(5):971-981. PubMed ID: 27890713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
    Florea V; Rieger AC; DiFede DL; El-Khorazaty J; Natsumeda M; Banerjee MN; Tompkins BA; Khan A; Schulman IH; Landin AM; Mushtaq M; Golpanian S; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Valasaki K; Pujol MV; Ghersin E; Miki R; Delgado C; Abuzeid F; Vidro-Casiano M; Saltzman RG; DaFonseca D; Caceres LV; Ramdas KN; Mendizabal A; Heldman AW; Mitrani RD; Hare JM
    Circ Res; 2017 Nov; 121(11):1279-1290. PubMed ID: 28923793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral transplantation of autologous adipose-derived stem cells for chronic ischemic stroke: A phase I study.
    Chiu TL; Baskaran R; Tsai ST; Huang CY; Chuang MH; Syu WS; Harn HJ; Lin YC; Chen CH; Huang PC; Wang YF; Chuang CH; Lin PC; Lin SZ
    J Tissue Eng Regen Med; 2022 Jan; 16(1):3-13. PubMed ID: 34644444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
    Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
    Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
    Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
    Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.
    Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY;
    Trials; 2013 Oct; 14():317. PubMed ID: 24083670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial.
    de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E
    Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
    Ringelstein EB; Thijs V; Norrving B; Chamorro A; Aichner F; Grond M; Saver J; Laage R; Schneider A; Rathgeb F; Vogt G; Charissé G; Fiebach JB; Schwab S; Schäbitz WR; Kollmar R; Fisher M; Brozman M; Skoloudik D; Gruber F; Serena Leal J; Veltkamp R; Köhrmann M; Berrouschot J;
    Stroke; 2013 Oct; 44(10):2681-7. PubMed ID: 23963331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.